Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Influenza A H7N9 Neuraminidase (NA)

Cat. No.VG9F123

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Influenza A H7N9 Neuraminidase (NA) is a recombinant protein expressed from HEK293 Cells.

Specifications

Type Recombinant Protein
Species Virus
Expression System HEK293 Cells
Physical State Lyophilized
Formulation PBS, 0.6%Triton-100, 6% trehalose 5.3% mannitol PH 7.4.

Target Information

H7N9 avian influenza virus can cause severe infections and has the potential to spark a major pandemic. Influenza viruses have two primary surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA). HA is responsible for the attachment of virions to terminal sialic acids (SAs) on the cell surface and facilitates the fusion of the virus with cellular membranes. NA cleaves terminal SA residues on the host cell surfaces, aiding in the release of progeny virions from infected cells.

Protein Influenza A H7N9 Neuraminidase (NA)
Protein Synonym Neuraminidase; NA
EC No. 3.2.1.18

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket